Categorie -wet- en regelgeving

bv CGR, GDPR

Five things for pharma marketers to know:

wet- en regelgeving

Five things for pharma marketers to know: Wednesday, November 29, 2023

29 november 2023

MMM - Medical Marketing and Media

Nieuwe behandeling voor sikkelcelziekte en thalassemie goedgekeurd in VK

wet- en regelgeving

Nieuwe behandeling voor sikkelcelziekte en thalassemie goedgekeurd in VK

21 november 2023

NOS Algemeen

FDA approves Pfizer & Astellas' Xtandi for earlier prostate cancer treatment setting

wet- en regelgeving

US FDA approves Pfizer & Astellas’ Xtandi for earlier prostate cancer treatment setting

20 november 2023

Pharma Biz

Takeda's enzyme replacement therapy approved by FDA for rare blood clotting disorder

wet- en regelgeving

Takeda’s enzyme replacement therapy approved by FDA for rare blood clotting disorder

14 november 2023

PMLiVE

Five things for pharma marketers to know:

wet- en regelgeving

Five things for pharma marketers to know: Monday, November 13, 2023

13 november 2023

MMM - Medical Marketing and Media

wet- en regelgeving

Europese plannen medicijnwetgeving slecht voor gezondheid en innovatie

10 november 2023

Pharmamarketeer™

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer